[{"data":1,"prerenderedAt":167},["ShallowReactive",2],{"drug-influenza-vaccine":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":22,"regimens":35,"contraindications":60,"warnings":70,"renal":71,"monitoring":72,"interactions":73,"review":74,"examples":77,"atc":83,"iran":85,"links":113,"populations":128,"usApproval":162},"influenza-vaccine",1,{"fa":7,"en":8},"واکسن آنفلوانزا (غیرفعال)","Influenza vaccine (inactivated)","anti-infectives",{"fa":11,"en":12},"واکسن غیرفعال","Inactivated vaccine",[14],{"name":15,"market":16},"Fluzone","US",[18,19,20,21],"fluzone","vaxigrip","واکسن آنفولانزا","flu shot",[23],{"id":24,"form":25,"route":26,"label":27,"concentration":28,"markets":30,"refs":31},"syr-05","injection","im","0.5 mL prefilled syringe \u002F multidose vial",{"amount":5,"unit":29,"perVolumeMl":5},"mL",[16],[32],{"source":33,"section":34},"fda-fluzone","3",[36],{"id":37,"disease":38,"label":39,"population":42,"type":46,"unit":29,"dose":47,"refs":49,"durationDays":52,"notes":53},"std","immunization",{"fa":40,"en":41},"سالانه — ۶ ماه به بالا: ۰٫۵ mL عضلانی (۶ تا ۳۵ ماه: ۰٫۲۵ یا ۰٫۵ mL)","Yearly — ≥6 months: 0.5 mL IM (6–35 months: 0.25 or 0.5 mL)",{"minAge":43},{"value":44,"unit":45},6,"month","fixed",{"perDose":48,"dosesPerDay":5},0.5,[50],{"source":33,"section":51},"2.1, Table 1",{"min":5,"max":5},[54],{"text":55,"refs":58},{"fa":56,"en":57},"۶ ماه تا ۸ سال که قبلاً واکسن نزده‌اند: ۲ دوز با فاصله دست‌کم ۴ هفته. ۶ تا ۳۵ ماه: هر دوز ۰٫۲۵ یا ۰٫۵ mL. ۹ سال به بالا: یک دوز ۰٫۵ mL.","6 months–8 y not previously vaccinated: 2 doses at least 4 weeks apart. 6–35 months: each dose 0.25 or 0.5 mL. ≥9 y: one 0.5 mL dose.",[59],{"source":33,"section":51},[61],{"id":62,"severity":63,"text":64,"refs":67},"allergy","block",{"fa":65,"en":66},"واکنش آلرژیک شدید به اجزای واکسن (از جمله پروتئین تخم‌مرغ) یا دوز قبلی هر واکسن آنفلوانزا.","Severe allergic reaction to a component (including egg protein) or a previous dose of any influenza vaccine.",[68],{"source":33,"section":69},"4",[],[],[],[],{"status":75,"reviewer":76,"date":76},"unverified",null,[78],{"regimen":37,"formulation":24,"input":79,"expect":82},{"ageYears":80,"weightKg":81},30,70,{"perDose":48,"mlPerDose":48},[84],"J07BB02",{"status":86,"forms":87,"refs":108},"registered",[88,92,96,100,104],{"code":89,"en":90,"fa":91},"14786","VACCINE-INFLUENZA A 15MCG 0.5ML VIAL","ویال واکسن–آنفلوانزا A ۱۵ میکروگرم ۰٫۵ میلی‌لیتر",{"code":93,"en":94,"fa":95},"14785","VACCINE-INFLUENZA A 3.8MCG 0.5ML VIAL","ویال واکسن–آنفلوانزا A ۳٫۸ میکروگرم ۰٫۵ میلی‌لیتر",{"code":97,"en":98,"fa":99},"00667","VACCINE-INFLUENZA VIRUS KILLED SYRINGE","سرنگ واکسن–آنفلوانزا ویروس کیللد",{"code":101,"en":102,"fa":103},"52695","INFLUENZA VACCINE, INACTIVATED, TETRAVALENT INJECTION PARENTERAL 1 {dose}","فرآورده تزریقی واکسن آنفلوانزا غیرفعال‌شده تتراوالنت ۱ { دوز }",{"code":105,"en":106,"fa":107},"53020","INFLUENZA VACCINE, RECOMBINANT, TETRAVALENT INJECTION PARENTERAL 1 {dose} 0.5 mL","فرآورده تزریقی واکسن آنفلوانزا نوترکیب تتراوالنت ۱ { دوز } ۰٫۵ میلی‌لیتر",[109],{"source":110,"section":111,"url":112},"darooyab-generic","G-3474\u002FInfluenza-Vaccines","https:\u002F\u002Fwww.darooyab.ir\u002FG-3474\u002FInfluenza-Vaccines",[114,118,122,125],{"kind":115,"url":116,"label":117},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=103914","BLA103914",{"kind":119,"url":120,"label":121},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=5fe0ce14-bc11-4b43-b002-7efdca0d3003","FDA Fluzone",{"kind":123,"url":124,"label":84},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=J07BB02",{"kind":126,"url":112,"label":127},"darooyab","Influenza-Vaccines",{"pregnancy":129,"lactation":138,"pediatric":146,"geriatric":154},{"level":130,"text":131,"quote":134,"refs":135},"caution",{"fa":132,"en":133},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Risk Summary All pregnancies have a risk of birth defect, loss, or other adverse outcomes.",[136],{"source":33,"section":137},"8.1",{"level":130,"text":139,"quote":142,"refs":143},{"fa":140,"en":141},"برچسب: در شیردهی با احتیاط؛ متن برچسب را ببینید.","Label: use with caution while breastfeeding; see the label text.","It is not known if Fluzone is excreted in human milk.",[144],{"source":33,"section":145},"8.2",{"level":130,"text":147,"quote":150,"refs":151},{"fa":148,"en":149},"برچسب برای کودکان شرط، محدودیت سنی یا نکته دارد؛ جمله برچسب در زیر آمده است.","The label has conditions, age limits or notes for children; the label sentence is quoted below.","Safety and effectiveness of Fluzone in children below the age of 6 months have not been established.",[152],{"source":33,"section":153},"8.4",{"level":130,"text":155,"quote":158,"refs":159},{"fa":156,"en":157},"برچسب: در سالمندان با احتیاط و معمولاً از دوز پایین شروع شود.","Label: use with caution in older adults, usually starting at the low end of the dose range.","Safety and immunogenicity of Fluzone were evaluated in adults 65 years of age and older.",[160],{"source":33,"section":161},"8.5",{"kind":163,"refs":164,"id":117},"BLA",[165],{"source":33,"section":166},"SPL approval \u002F marketing category",1792108426315]